Vascular access in patients receiving prolonged chemotherapy is a difficult problem. This led to the introduction of a totally implanted device. We intend to assess the efficacy of this device in a subset of oncologic patients. Between May 1989 and November 1992, 129 devices were placed in 123 adult
Long-term experience with a totally implanted catheter system in cancer patients
β Scribed by Cesar O. Freytes; Patricia Reid; Kirby L. Smith
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 383 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ninety-eight single lumen and two double lumen silicone right atrial Hickman/Broviac catheters inserted in 9 1 patients with various malignancies over a period of 36 months were prospectively studied. The average duration of use for all Hickman/Broviac catheters was 7,460 days with an average of 74.
In this study of 10 patients with central venous access system, the reservoir body was implanted in the lower limb. Only one complication was observed per 1,560 days of function time. The anterolateral distal half of the thigh is a good alternative site for the injection port in cancer patients whos